Literature DB >> 10604987

Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1.

D B Schubart1, A Rolink, K Schubart, P Matthias.   

Abstract

OBF-1 is a B cell-restricted transcriptional coactivator that is recruited to octamer-containing promoters by interacting with the POU domain of Oct-1 or Oct-2. We have shown earlier that mice lacking OBF-1 were dramatically impaired in their ability to mount humoral immune responses and did not develop germinal centers in the spleen; however, they had a largely normal B cell development in the bone marrow. In this study, we demonstrate that OBF-1-deficient mice also have an early defect in B cell development and show that OBF-1-/- immature B cells are greatly impaired at the transition from the bone marrow to the spleen. In addition, when the OBF-1 mutation is combined to a mutation in the gene encoding Bruton's tyrosine kinase, a striking phenotype is observed. These double-deficient animals lack peripheral B cells and have virtually no serum Igs, thus closely resembling human X chromosome-linked agammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10604987     DOI: 10.4049/jimmunol.164.1.18

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  A new class of errant DNA polymerases provides candidates for somatic hypermutation.

Authors:  B Tippin; M F Goodman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

2.  The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.

Authors:  J Hess; P J Nielsen; K D Fischer; H Bujard; T Wirth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication.

Authors:  Xiaodi Ren; Rachael Siegel; Unkyu Kim; Robert G Roeder
Journal:  Mol Cell       Date:  2011-05-06       Impact factor: 17.970

4.  The Ets factor Spi-B is a direct critical target of the coactivator OBF-1.

Authors:  Boris Bartholdy; Camille Du Roure; Alain Bordon; Dianne Emslie; Lynn M Corcoran; Patrick Matthias
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-21       Impact factor: 11.205

5.  Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema.

Authors:  Nicola Marchi; Giulia Betto; Vincent Fazio; Quinyuan Fan; Chaitali Ghosh; Andre Machado; Damir Janigro
Journal:  Epilepsia       Date:  2009-01-21       Impact factor: 5.864

6.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

7.  A C-terminal acidic domain regulates degradation of the transcriptional coactivator Bob1.

Authors:  John M Lindner; Christina S F Wong; Andreas Möller; Peter J Nielsen
Journal:  Mol Cell Biol       Date:  2013-09-23       Impact factor: 4.272

8.  A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase.

Authors:  A B Satterthwaite; F Willis; P Kanchanastit; D Fruman; L C Cantley; C D Helgason; R K Humphries; C A Lowell; M Simon; M Leitges; A Tarakhovsky; T F Tedder; R Lesche; H Wu; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

9.  Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development.

Authors:  Alain Bordon; Nabil Bosco; Camille Du Roure; Boris Bartholdy; Hubertus Kohler; Gabriele Matthias; Antonius G Rolink; Patrick Matthias
Journal:  PLoS One       Date:  2008-12-23       Impact factor: 3.240

10.  Btk expression is controlled by Oct and BOB.1/OBF.1.

Authors:  Cornelia Brunner; Thomas Wirth
Journal:  Nucleic Acids Res       Date:  2006-03-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.